SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SRGN ( Seragen, Inc.)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: celeryroot.com who wrote (43)5/19/1998 11:54:00 AM
From: Phil Cressman  Read Replies (1) of 52
 
Hi guys, Fully agree with your figures, No risk play in my view at current prices. If LGND ever starts attracting interest and their share price rises, SRGN must rise further. I still feel a price of 60 cents a share for SRGN represents fair market at this time. I believe the 3rd quarter is when the first installment (Ligand shares) will be paid over. It will be interesting to see how the market will then value the SRGN shares, a dime would be my guess (I'm also betting that those $14 LGND shares will be worth $16 to $20 by then.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext